(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according to a study recently published in JAMA Oncology.
Mar 1, 2019
0
2
(HealthDay)—While genetics, such as carrying BRCA gene mutations, play a role in who is more likely to get breast cancer, everyday lifestyle factors are involved, too.
Mar 1, 2019
0
0
Cancer clinical trials are an important option for patients with cancer. Yet, once a trial ends, patients still need care plans. Little is known at what point during clinical trial transitions to initiate advance planning ...
Feb 19, 2019
0
1
An increasing number of new anti-cancer drugs are approved each year. During the authorization process, such new drugs usually undergo comparisons to other single drugs, but only rarely to multiple established drugs. This ...
Feb 14, 2019
0
0
The immunotherapy that has revolutionized treatment of many cancers appears to offer similar benefit to cancer patients living with HIV, say researchers at Georgetown Lombardi Comprehensive Cancer Center.
Feb 7, 2019
0
4
New rules recently went into effect, seeking to protect patients who donate tissue samples for research in the age of genetic sequencing. But this rule could have unintended consequences for certain critical types of biospecimens.
Jan 31, 2019
1
5
In long-term survivors of childhood cancer, cardiovascular disease is a leading cause of early death from non-cancer causes. In a new study, published Jan. 31 in JAMA Oncology, researchers compared four chemotherapy drugs ...
Jan 31, 2019
0
4
Results from the largest study of hepatitis B and C and HIV infection prevalence in cancer patients show an alarmingly high rate of undiagnosed acute and chronic hepatitis B and C. Hepatitis B and C are serious but treatable ...
Jan 17, 2019
0
5
Cancer patients with other illnesses or conditions, such as hypertension, asthma, or a prior cancer, are less likely to talk with their health care provider about a cancer clinical trial, are less likely to be offered to ...
Jan 10, 2019
0
0
(HealthDay)—Combined modality treatment (CMT) is associated with improved overall survival in pediatric patients with early-stage Hodgkin lymphoma (HL), according to a study published online Jan. 3 in JAMA Oncology.
Jan 9, 2019
0
0
